Next Issue
Volume 14, 05
Previous Issue
Volume 14, 03
 
 
cardiovascmed-logo

Journal Browser

Journal Browser
Cardiovascular Medicine is published by MDPI from Volume 28 Issue 1 (2025). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Editores Medicorum Helveticorum (EMH).

Cardiovasc. Med., Volume 14, Issue 4 (04 2011) – 6 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
  • You may sign up for e-mail alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Order results
Result details
Select all
Export citation of selected articles as:
1 pages, 88 KB  
Editorial
Research Prize 2012 of the Swiss Heart Foundation
by Swiss Heart Foundation
Cardiovasc. Med. 2011, 14(4), 136; https://doi.org/10.4414/cvm.2011.01582 - 20 Apr 2011
Viewed by 15
Abstract
The Swiss Heart Foundation (SHF) awards an annual prize of 20,000 Swiss Francs for one or more outstanding publications / accepted manuscripts of scientific research in the field of the prevention, diagnosis and/or treatment of cardiovascular diseases [...] Full article
3 pages, 233 KB  
Case Report
Sudden Cardiac Death in Tako-Tsubo Syndrome: A Possible Mechanism
by Eleni Goulouti and Alain Delabays
Cardiovasc. Med. 2011, 14(4), 131; https://doi.org/10.4414/cvm.2011.01583 - 20 Apr 2011
Cited by 2 | Viewed by 12
Abstract
The left ventricular “apical ballooning” syndrome, also known as “Tako-Tsubo syndrome”, has been the subject of numerous studies and reports in the literature, to the point that the term “stress-induced cardiomyopathy” has been coined. It is characterized by transient left ventricular apical ballooning [...] Read more.
The left ventricular “apical ballooning” syndrome, also known as “Tako-Tsubo syndrome”, has been the subject of numerous studies and reports in the literature, to the point that the term “stress-induced cardiomyopathy” has been coined. It is characterized by transient left ventricular apical ballooning associated with electrocardiographic changes and minimal myocardial enzymatic release, mimicking acute myocardial infarction in patients without significant coronary disease at angiography. We report the case of a 70-year-old woman suffering from Tako-Tsubo cardiomyopathy, who presented with long-QT and cardiac arrest secondary to “‘torsade de pointes”. Full article
4 pages, 237 KB  
Case Report
High-Risk Pulmonary Embolism with Impending Paradoxical Embolism Successfully Treated with Percutaneous Catheter-Based Thrombectomy
by Chan-il Park, Marco Roffi, Stéphane Noble, Chirine Parsai, Amir-Ali Fassa, Paolo Merlani and Robert Francis Bonvinia
Cardiovasc. Med. 2011, 14(4), 127; https://doi.org/10.4414/cvm.2011.01580 - 20 Apr 2011
Cited by 7 | Viewed by 16
Abstract
Impending paradoxical embolism is a rare condition defined as the presence of an entrapped thrombus through the patent foramen ovale. This diagnosis is usually made from echocardiography or a thoracic-CT scan performed in patients with suspected pulmonary embolism (PE) or paradoxical embolism. We [...] Read more.
Impending paradoxical embolism is a rare condition defined as the presence of an entrapped thrombus through the patent foramen ovale. This diagnosis is usually made from echocardiography or a thoracic-CT scan performed in patients with suspected pulmonary embolism (PE) or paradoxical embolism. We report the case of a 72-year-old patient presenting with highrisk PE, acute ischaemic stroke and a large impending paradoxical embolism successfully treated percutaneously. We will finally focus the discussion on the acute management of high-risk PE in patients with contraindications to systemic thrombolysis or surgical embolectomy. Full article
8 pages, 528 KB  
Article
Collateral Function Changes During Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction: Effect on Infarct Size
by Andrea Remondino, Christian Seiler, Pascal Meier, Roby D. Rakhit, Kerstin Wustmann, Rainer Zbinden, Stephan Zbinden, Stephan Windecker, Mario Togni, Peter Wenaweser, Bernhard Meier and Franz R. Eberli
Cardiovasc. Med. 2011, 14(4), 119; https://doi.org/10.4414/cvm.2011.01579 - 20 Apr 2011
Viewed by 16
Abstract
Background: This study in patients undergoing primary percutaneous coronary intervention (PCI) for acute myocardial infarction sought to test the hypotheses that collateral flow index (CFI) is reduced after unprotected recanalisation, or unaltered with protected PCI, and that collateral flow is related to [...] Read more.
Background: This study in patients undergoing primary percutaneous coronary intervention (PCI) for acute myocardial infarction sought to test the hypotheses that collateral flow index (CFI) is reduced after unprotected recanalisation, or unaltered with protected PCI, and that collateral flow is related to infarct size. Methods and results: 46 patients (age 63 ± 12 years, 36 men, 10 women) with acute myocardial infarction underwent primary PCI of the occluded culprit vessel. Coronary collateral degree was assessed angiographically (score 0–3) before recanalisation of the occlusion. A sensor guide wire (Doppler or pressure sensor) was used for PCI to obtain CFI during the first two balloon occlusions. The study population was divided into two groups depending on the use of a coronary distal embolisation protection device (without protection device: n = 29, with protection device: n = 17). Infarct size was determined using serial serum creatine phosphokinase (CK) measurements up to 24 hours after PCI. There was an inverse relation between angiographic coronary collateral degree as obtained before PCI and peak CK level. In the group without but not with protection device, however, there was a trend to a direct relation between CFI and peak CK level. The CFI change between the 1st and 2nd balloon occlusions was –0.032 in the group without a protection device (p = 0.049), and +0.002 in the group with a protection device (p = 0.73). Conclusion: In patients with acute myocardial infarction, collateral function becomes impaired following primary PCI in the absence but not in the presence of a distal coronary embolisation protection device. Coronary collateral degree obtained prior to PCI, but not collateral function determined during PCI, is inversely predictive of infarct size. Our study indicates that the latter is probably related to the fact that pressure- derived CFI in acute myocardial infarction reflects elevated left ventricular filling pressure rather than collateral function. Full article
8 pages, 472 KB  
Review
Is Selective Heart Rate Reduction a New Therapeutic Principle in Heart Failure?
by Frank Enseleit, Thomas F. Lüscher and Frank Ruschitzka
Cardiovasc. Med. 2011, 14(4), 111; https://doi.org/10.4414/cvm.2011.01584 - 20 Apr 2011
Viewed by 16
Abstract
In industrialised countries, chronic heart failure affects 2–3% of the general population. It is an increasingly recognised cause of morbidity and mortality. In the past decades, a successful launch of new therapeutic means has led to improved outcomes, but the prognosis remains fairly [...] Read more.
In industrialised countries, chronic heart failure affects 2–3% of the general population. It is an increasingly recognised cause of morbidity and mortality. In the past decades, a successful launch of new therapeutic means has led to improved outcomes, but the prognosis remains fairly poor. In patients with heart failure, high heart rates are a negative prognostic predictor and can cause heart failure per se. A direct association between heart rate and cardiovascular outcomes has been observed, in beta-blocker trials in particular. Ivabradine, the bencyclobutane derivate S16257, is a highly selective heart-rate-lowering agent that acts by inhibiting the pacemaker ionic current If in sinoatrial node cells. Since the development of ivabradine, a drug with no apparent cardiovascular effects other than heart rate slowing, it has become possible to selectively explore the effects of heart rate lowering separate from other cardiovascular effects (e.g., negative inotropism among others). Furthermore, it has become possible to test the hypothesis of whether therapeutic heart rate modulation reduces morbidity and mortality in heart failure patients. This hypothesis was tested in the recently published Systolic Heart failure treatment with the IF inhibitor ivabradine Trial (SHIFT). Full article
2 pages, 274 KB  
Editorial
Ake Senning—Pionier der Schweizer Herzchirurgie in Zürich: Zu seinem 10. Todestag und zum 50-Jahr-Jubiläum der Herzchirurgie am UniversitätsSpital Zürich
by Hans A. Säuberli
Cardiovasc. Med. 2011, 14(4), 109; https://doi.org/10.4414/cvm.2011.01585 - 20 Apr 2011
Viewed by 16
Abstract
Anfang der 60er Jahre beschloss die medizinische Fakultät der Universität Zürich, den Chefarztposten der neu geschaffenen chirurgischen Klinik A mit dem Herzchirurgen Ake Senning aus Schweden zu besetzen. Es war dies in der damaligen Zeit eine mutige und weitsichtige Entscheidung. Ein kurzer Rückblick [...] Read more.
Anfang der 60er Jahre beschloss die medizinische Fakultät der Universität Zürich, den Chefarztposten der neu geschaffenen chirurgischen Klinik A mit dem Herzchirurgen Ake Senning aus Schweden zu besetzen. Es war dies in der damaligen Zeit eine mutige und weitsichtige Entscheidung. Ein kurzer Rückblick soll uns vor Augen führen, auf wessen «Schultern» wir in dieser heute noch bewunderten Disziplin stehen [...] Full article
Previous Issue
Next Issue
Back to TopTop